Alembic Pharma Receives USFDA Approval for Valganciclovir Oral Solution
Alembic Pharmaceuticals receives USFDA final approval for Valganciclovir for Oral Solution, marking its 247th ANDA approval and strengthening its US portfolio.
USFDA
Latest USFDA stock news from NSE and BSE filings, 4 stories so far.
Fund Raise
Astal Laboratories Ltd to Raise ₹300 Crore for USFDA Pharma Unit Acquisitions
Astal Laboratories Ltd (512600) announces a ₹300 Crore fund raise via private placement and a strategic mandate to acquire USFDA or EU-GMP compliant units in India.
